Pactiv Evergreen Inc. Common stock
PTVE
PTVE was delisted on the 31st of March, 2025.
65 hedge funds and large institutions have $467M invested in Pactiv Evergreen Inc. Common stock in 2020 Q3 according to their latest regulatory filings, with 65 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$104M |
| 2 |
JP Morgan Chase
New York
|
+$85.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$25.2M |
| 5 |
CCM
CAAS Capital Management
New York
|
+$23.6M |
Top Sellers
PTVE Hedge Fund Activity: Q3 2020 in Review
65 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q3 2020, worth a combined $467M.
Buyers outnumbered sellers: 65 funds opened new PTVE positions and 0 closed out — a net gain of 65 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Nuveen, opening a new position worth an estimated $104M.
- 65 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $467M of Pactiv Evergreen Inc. Common stock stock for Q3 2020.
- 65 funds opened new Pactiv Evergreen Inc. Common stock positions in Q3 2020 and 0 closed out, a net change of +65 holders.
- The largest Pactiv Evergreen Inc. Common stock buyer in Q3 2020 was Nuveen, an estimated $104M added.
Based on aggregated 13F filings for Q3 2020.